The Added Cost of Rapid Diagnostic Testing and Active Antimicrobial Stewardship: Is It Worth It?
Journal of Clinical Microbiology January 2017 V.55 N.1 P.20-23
Erin McElvania TeKippe
Departments of Pathology and Pediatrics, University of Texas Southwestern and Departments of Pathology and Laboratory Medicine, Children’s Health, Dallas, Texas, USA
Rapid diagnostic testing reduces the turnaround time for pathogen identification in the clinical microbiology laboratory, but the impact on patient care and hospital costs is a matter of speculation.
Patel et al. (J. Clin. Microbiol. 55:60–67, 2017, https://doi.org/10.1128/JCM.01452-16) investigate the impact of matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) in conjunction with active antimicrobial stewardship to determine if implementation is indeed worth the added costs.